J B Chemicals & Pharmaceuticals rose 3.08% to Rs 1066.80 after the company said it received US drug regulator's approval for its Abbreviated New Drug Application (ANDA) of Loratadine tablets.
Loratadine tablets are used for treating allergic rhinitis caused by pollen and upper respiratory tract allergy. The product is generic version of Clartin tablet in the same strength of Bayer Healthcare LLC.The company said it expects to commercialize this product in Q1 of FY 2021-22 and is expected to improve its US sales.
J B Chemicals & Pharmaceuticals manufactures and markets a range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (APIs). The firm's business segments include domestic formulation business, exports and API business.
% On a consolidated basis, the company's net profit declined 21.1% to Rs 73.82 crore on a 2.8% decline in net sales to Rs 443.56 crore in Q2 September 2020 over Q2 September 2019.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app